253 related articles for article (PubMed ID: 11722282)
1. Pharmacogenetics--legal, ethical and regulatory considerations.
March R; Cheeseman K; Doherty M
Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
[TBL] [Abstract][Full Text] [Related]
2. Informed consent in the context of pharmacogenomic research: ethical considerations.
Howard HC; Joly Y; Avard D; Laplante N; Phillips M; Tardif JC
Pharmacogenomics J; 2011 Jun; 11(3):155-61. PubMed ID: 21445091
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and ethical considerations: why care?
Marx-Stölting L
Pharmacogenomics J; 2007 Oct; 7(5):293-6. PubMed ID: 17033614
[No Abstract] [Full Text] [Related]
4. Family consent and the pursuit of better medicines through genetic research.
Renegar G; Rieser P; Manasco P
J Contin Educ Health Prof; 2001; 21(4):265-70. PubMed ID: 11803771
[TBL] [Abstract][Full Text] [Related]
5. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
Morley KI; Hall WD
J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics: ethical issues and policy options.
Buchanan A; Califano A; Kahn J; McPherson E; Robertson J; Brody B
Kennedy Inst Ethics J; 2002 Mar; 12(1):1-15. PubMed ID: 12211263
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics: the Rx perspective.
Renegar G; Rieser P; Manasco P
Expert Rev Mol Diagn; 2001 Sep; 1(3):255-63. PubMed ID: 11901830
[TBL] [Abstract][Full Text] [Related]
8. Ethics and policy perspectives on personalized medicine in the post-genomic era.
Landon MR
J Biolaw Bus; 2005; 8(3):28-36. PubMed ID: 16459425
[TBL] [Abstract][Full Text] [Related]
9. Erice declaration of the ethical principles of pharmacogenetic research. Temporary Committee on Human Genetics and Other New Technologies of Modern Medicine.
Temporary Committee on Human Genetics and Other New Technologies of Modern Medicine
Rev Derecho Genoma Hum; 2002; (17):223-8. PubMed ID: 12703117
[No Abstract] [Full Text] [Related]
10. Society and ethics - the genetics of disease.
Thomas SM
Curr Opin Genet Dev; 2004 Jun; 14(3):287-91. PubMed ID: 15172672
[TBL] [Abstract][Full Text] [Related]
11. Nuffield Council on Bioethics consultation.
Lipton P
Pharmacogenomics; 2003 Jan; 4(1):91-5. PubMed ID: 12517289
[TBL] [Abstract][Full Text] [Related]
12. Privacy issues in personalized medicine.
Vaszar LT; Cho MK; Raffin TA
Pharmacogenomics; 2003 Mar; 4(2):107-12. PubMed ID: 12605543
[TBL] [Abstract][Full Text] [Related]
13. Challenges and pitfalls in the introduction of pharmacogenetics for cancer.
Loh M; Soong R
Ann Acad Med Singap; 2011 Aug; 40(8):369-74. PubMed ID: 22065003
[TBL] [Abstract][Full Text] [Related]
14. Reprogenetics and pharmacogenetics: in whose best interests?
Mackenzie R
Med Law; 2005 Jun; 24(2):343-54. PubMed ID: 16082870
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report.
Corrigan OP
J Med Ethics; 2005 Mar; 31(3):144-8. PubMed ID: 15738433
[TBL] [Abstract][Full Text] [Related]
16. Context, ethics and pharmacogenetics.
Hedgecoe AM
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):566-82. PubMed ID: 16980195
[TBL] [Abstract][Full Text] [Related]
17. Consent and privacy in pharmacogenetic testing.
Robertson JA
Nat Genet; 2001 Jul; 28(3):207-9. PubMed ID: 11431685
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics and public policy: expert views in Europe and North America.
Melzer D; Detmer D; Zimmern R
Pharmacogenomics; 2003 Nov; 4(6):689-91. PubMed ID: 14596633
[TBL] [Abstract][Full Text] [Related]
19. [Ethics, politics, and rights in pharmacogenomics].
Bellver Capella V
Rev Derecho Genoma Hum; 2002; (17):31-55. PubMed ID: 12703107
[TBL] [Abstract][Full Text] [Related]
20. Ethical, social and legal implications of pharmacogenomics: a critical review.
Moldrup C
Community Genet; 2001; 4(4):204-14. PubMed ID: 12751484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
